Drug Resistance in Tuberculous Lymphadenitis: Molecular Characterization.
Assefa G, Desta K, Araya S, Girma S, Hailu E, Mihret A, Hailu T, Tilahun M, Diriba G, Dagne B, Atnafu A, Endalafer N, Abera A, Bekele S, Mengistu Y, Bobosha K, Aseffa A.
Assefa G, et al. Among authors: atnafu a.
Tuberc Res Treat. 2023 Mar 29;2023:3291538. doi: 10.1155/2023/3291538. eCollection 2023.
Tuberc Res Treat. 2023.
PMID: 37032734
Free PMC article.